ArticleHepatobiliary surgery and nutrition2026

Advancing TCR-T cell therapy in hepatocellular carcinoma: lessons from the ADP-A2AFP trial.

Zuzana Macek Jilkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.